Delayed
BME
08:30:29 23/01/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.69
EUR
|
-.--%
|
|
-.--%
|
+1.47%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
39.84
|
74.08
|
14.18
|
7.63
|
11.42
|
6.341
|
Enterprise Value (EV)
1 |
52.86
|
83.05
|
14.18
|
17.07
|
22.75
|
21.15
|
P/E ratio
|
-16.4
x
|
-10.1
x
|
3.43
x
|
-4.15
x
|
-8.73
x
|
-3.99
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.39
x
|
3.04
x
|
0.64
x
|
0.41
x
|
0.5
x
|
0.25
x
|
EV / Revenue
|
1.85
x
|
3.41
x
|
0.64
x
|
0.92
x
|
1
x
|
0.85
x
|
EV / EBITDA
|
-54.4
x
|
-11.8
x
|
19.2
x
|
27.5
x
|
19.7
x
|
14.4
x
|
EV / FCF
|
25.6
x
|
22
x
|
-
|
-8.25
x
|
-16.8
x
|
-8.2
x
|
FCF Yield
|
3.91%
|
4.54%
|
-
|
-12.1%
|
-5.95%
|
-12.2%
|
Price to Book
|
4.17
x
|
22.2
x
|
-
|
1.89
x
|
4.16
x
|
6.27
x
|
Nbr of stocks (in thousands)
|
11,066
|
10,894
|
12,895
|
12,933
|
12,974
|
12,940
|
Reference price
2 |
3.600
|
6.800
|
1.100
|
0.5900
|
0.8800
|
0.4900
|
Announcement Date
|
07/05/18
|
02/05/19
|
06/07/20
|
15/05/21
|
28/04/22
|
18/04/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
28.57
|
24.35
|
22.26
|
18.56
|
22.82
|
24.92
|
EBITDA
1 |
-0.9708
|
-7.044
|
0.7403
|
0.6214
|
1.158
|
1.465
|
EBIT
1 |
-2.367
|
-8.102
|
0.029
|
-0.1092
|
0.387
|
0.5474
|
Operating Margin
|
-8.29%
|
-33.27%
|
0.13%
|
-0.59%
|
1.7%
|
2.2%
|
Earnings before Tax (EBT)
1 |
-3.269
|
-9.556
|
4.484
|
-1.799
|
-1.502
|
-1.654
|
Net income
1 |
-2.403
|
-8.497
|
4.162
|
-1.838
|
-1.303
|
-1.588
|
Net margin
|
-8.41%
|
-34.89%
|
18.7%
|
-9.9%
|
-5.71%
|
-6.37%
|
EPS
2 |
-0.2189
|
-0.6759
|
0.3206
|
-0.1421
|
-0.1008
|
-0.1229
|
Free Cash Flow
1 |
2.064
|
3.769
|
-
|
-2.069
|
-1.355
|
-2.581
|
FCF margin
|
7.23%
|
15.48%
|
-
|
-11.15%
|
-5.94%
|
-10.36%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
07/05/18
|
02/05/19
|
06/07/20
|
15/05/21
|
28/04/22
|
18/04/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
13
|
8.97
|
-
|
9.44
|
11.3
|
14.8
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-13.41
x
|
-1.274
x
|
-
|
15.18
x
|
9.789
x
|
10.11
x
|
Free Cash Flow
1 |
2.06
|
3.77
|
-
|
-2.07
|
-1.35
|
-2.58
|
ROE (net income / shareholders' equity)
|
-51.8%
|
-257%
|
-
|
-37.1%
|
-38.7%
|
-86.1%
|
ROA (Net income/ Total Assets)
|
-4.22%
|
-18%
|
-
|
-0.29%
|
0.93%
|
1.24%
|
Assets
1 |
56.98
|
47.14
|
-
|
634.6
|
-140.1
|
-127.7
|
Book Value Per Share
2 |
0.8600
|
0.3100
|
-
|
0.3100
|
0.2100
|
0.0800
|
Cash Flow per Share
2 |
0.0400
|
0.0800
|
-
|
0.1300
|
0.1100
|
0.0800
|
Capex
1 |
0.84
|
0.39
|
0.5
|
1.42
|
2.34
|
1.14
|
Capex / Sales
|
2.93%
|
1.61%
|
2.25%
|
7.63%
|
10.24%
|
4.58%
|
Announcement Date
|
07/05/18
|
02/05/19
|
06/07/20
|
15/05/21
|
28/04/22
|
18/04/23
|
|
1st Jan change
|
Capi.
|
---|
| +1.47% | 9.63M | | -10.47% | 8.71B | | -2.35% | 1.45B | | -5.50% | 1.39B | | -7.61% | 1.21B | | -16.38% | 878M | | +1.34% | 488M | | +3.96% | 443M | | -22.11% | 345M | | -2.51% | 218M |
Medical Equipment Wholesale
|